DATAMETREX EXPANDS OPERATIONS FOR MEDI-CALL TELEHEALTH APPLICATION


Toronto, Canada, February 22, 2022 – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") would like to provide an important update on its current operations for its Medi-Call Inc. telehealth mobile application.


- The Company has just finalized the recruitment of two new medical physicians based in British Columbia to meet the demand of this rapidly growing market.


- The Company has an existing established team of nurses in BC and Ontario.


We are looking forward to expanding into this new Telehealth vertical with the goal to provide faster treatment and care for patients and help physicians to efficiently manage appointments.


Medi-Call Overview

Medi-call is a subscription service that connects patients with doctors proactively.

It is an integrated grid system that connects patients with providers in real time.

  • Solving accessibility issues for patients living in rural or isolated communities or with limited mobility

  • Improving coordination and communication of treatment among healthcare team members and their patients

  • Facilitating mobile health care services including prescriptions



About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.


For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.


For further information, please contact:


Communications & Investor Relations


Kristina Colpitts Email: kristina@datametrex.com


Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements:


All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.



Recent Posts

See All

Toronto, Canada, September 22, 2022 – Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to report that it has received a Purchase Order (“P.O.”) from Lo